SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is trending due to its recent expansion into U.S.-made pharmaceutical products, sparking community discussion and high anticipation for significant government contracts focused on national security for domestic drug supply chains, alongside its ongoing pivot into advanced battery materials.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM Integrated Shipping Services is trending amid reports of competing takeover bids from major shipping firms like MSC and Hapag-Lloyd, following the board's rejection of an internal management-led buyout for significantly undervaluing the company. The community is actively speculating on a final acquisition price well above current levels, citing the company's robust asset value and the potential for special dividends, while also debating the impact of rising container freight rates and governmental approvals.

Macy's, Inc. engages in the retail of apparel, accessories, cosmetics, home furnishings, and other consumer goods. The firm's brands include Macy's, Bloomingdale's, and Bluemercury. It offers men's, women's, and children's apparel, women's accessories, intimate apparel, shoes, cosmetics, fragrances, as well as home and miscellaneous products. The company was founded by Rowland H. Macy in 1858 and is headquartered in New York, NY.

Macy`s Inc

Macy's Inc

Macy's is trending after reporting stronger-than-anticipated earnings and boosting its financial outlook, with its 'Bold New Chapter' strategy showing positive comparable sales growth, especially in luxury segments. The community is split, with many bullish on the turnaround and potential for further upside, while others voice caution over a conservative holiday forecast and broader retail sector challenges.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Helium is actively discussed following recent regulatory clarity and a new AT&T partnership, with the community closely watching its consolidating tokenomics as rewards shift to HNT, reinforcing its position within the growing DePIN sector.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is seeing heightened interest ahead of its upcoming SOL-1 Phase 3 wet AMD trial data release, with community optimism fueled by recent institutional buying, a new high-profile Chief Commercial Officer hire, and the early announcement, all signaling confidence for strong results and potential upside.

Moo Deng

MOODENG CRYPTO is trending as its community rallies around recent price increases and surging volume, with many speculating on significant further gains for the low market cap meme coin. Bullish sentiment is amplified by discussions of positive technical indicators, a potential major exchange listing, and a broader uptrend in the crypto market.

Coterra Energy Inc. is an independent oil and gas company engaged in the development, exploration and production of oil, natural gas, and Natural Gas Liquids. Its portfolio includes projects in the Permian Basin, the Marcellus Shale, and the Anadarko Basin. Coterra Energy was founded in 1989 and is headquartered in Houston, TX.

Coterra Energy Inc

Coterra Energy is trending due to its pending all-stock merger with Devon Energy, a deal valued at approximately $58 billion that aims to create a major U.S. shale producer focused on the Delaware Basin with substantial cost synergies. The community is actively discussing this strategic consolidation as a "game-changer" for the energy sector, anticipating enhanced scale and long-term value.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa Inc. ($V) is trending due to recent strong earnings and strategic moves into AI-driven commerce and stablecoin settlements, though its stock has seen volatility amid intense community debate over proposed credit card interest rate caps. Many investors are weighing the impact of these regulatory discussions against Visa's transaction-based revenue model, often viewing market reactions as an oversold buying opportunity.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending due to its recent Coinbase listing and community excitement over its high-throughput, compliant blockchain technology, validated by Google Cloud and a recent bank acquisition, positioning it as a potential future financial infrastructure for institutional adoption.

BCE, Inc. is a telecommunications and media company, which provides communication services to residential, business, and wholesale customers. It operates through the Bell Communication and Technology Services (Bell CTS) and bell media segments. The Bell CTS segment provides a wide range of communication products and services to consumers, businesses and government customers across Canada. The Bell Media segment includes conventional, specialty and pay television, digital media, radio broadcasting services, and out-of-home advertising services. The company was founded on February 25, 1970 and is headquartered in Verdun, Canada.

BCE Inc

BCE Inc. is trending as recent financials and the sustained high dividend polarize investors; the community is debating its deep value and strategic ventures like Ziply Fiber and AI partnerships against lingering concerns over debt and telecom sector growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wells Fargo & Company Forecasts Strong Price Appreciation for Viridian Therapeutics (NASDAQ:VRDN) Stock

Wells Fargo & Company boosted their price objective on shares of Viridian Therapeutics from $26.00 to $29.00 and gave the company an "equal weight" rating in a research report on Tuesday...

Y Intercept Hong Kong Ltd Buys 52,414 Shares of Viridian Therapeutics, Inc. $VRDN

Y Intercept Hong Kong Ltd increased its stake in Viridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) by 430.3% in the third quarter, according to the company in its most recent filing with the...

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN - Get Free Report) have earned an average rating of "Moderate Buy" from the fifteen analysts that are covering the stock, Marketbeat.com reports...

SG Americas Securities LLC Acquires 49,981 Shares of Viridian Therapeutics, Inc. $VRDN

SG Americas Securities LLC grew its holdings in Viridian Therapeutics, Inc. (NASDAQ:VRDN - Free Report) by 411.8% in the third quarter, according to the company in its most recent Form 13F filing...

Viridian Therapeutics (NASDAQ:VRDN) Reaches New 52-Week High - Still a Buy?

Viridian Therapeutics (NASDAQ:VRDN) Sets New 52-Week High - Still a Buy...

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today...

Viridian Therapeutics (NASDAQ:VRDN) Price Target Lowered to $40.00 at Truist Financial

Truist Financial cut their price objective on shares of Viridian Therapeutics from $41.00 to $40.00 and set a "buy" rating on the stock in a research report on Thursday...

Viridian Therapeutics Prepares for Transformational 2026

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering, developing and commercializing potential best-in-class medicines for serious and rare diseases, today...

Jennifer Tousignant Sells 2,272 Shares of Viridian Therapeutics (NASDAQ:VRDN) Stock

Viridian Therapeutics, Inc. (NASDAQ:VRDN - Get Free Report) insider Jennifer Tousignant sold 2,272 shares of the business's stock in a transaction on Wednesday, December 31st. The stock was sold at...

Viridian Therapeutics (NASDAQ:VRDN) Insider Sells $70,795.52 in Stock

Viridian Therapeutics, Inc. (NASDAQ:VRDN - Get Free Report) insider Jennifer Tousignant sold 2,272 shares of Viridian Therapeutics stock in a transaction that occurred on Wednesday, December 31st...

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$27.90
Prev Close	$28.75
Open	$28.77
Dividend Yield	0.00%
50-Day Moving Average	$31.74
Beta	1.07
Avg. Volume	1.54M
PE Ratio	-7.90

52-Week High	$34.29
52-Week Low	$9.90
Market Capitalization	$2.66B
EPS (Annual)	-$3.07
Price to Book	7.30
Revenue Per Employee	$2,111.89

VRDN
Viridian Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VRDN News

VRDNViridian Therapeutics Inc